Every day, tens of thousands of fertilized hen eggs are delivered to Sinovac laboratories in Beijing. Each egg is infected with the H1N1 virus, then incubated for three days. White-coated employees examine every egg individually before the virus is extracted and used to make a vaccine.
Sinovac Biotech Ltd. was the first company in the world to successfully complete clinical trials for an H1N1 vaccine.
It was also the first company approved by the Chinese government to produce millions of doses for the public. China is set to become the first country to begin mass inoculations sometime around the beginning of October.
According to Sinovac CEO Yin Weidong, the secret lies in years of vaccine research and development. Sinovac was the first and only company ever to create a vaccine for Severe Acute Respiratory Syndrome (SARS), the worldwide pandemic that left almost 350 people in China dead.
The SARS vaccine was never used. By the time it was discovered, the outbreak had subsided. However, the breakthrough has enabled Sinovac to stay ahead of the curve.Watch as the H1N1 vaccine is produced Read full article »